Neuropsychiatric disorders in adults undergoing chimeric antigen receptor T cells therapy for aggressive lymphomas and acute lymphoblastic leukemia.

Emole, Josephine; Lawal, Odunayo; Lupak, Oleksandra; Rangarajan, Hemalatha; Udo, Itoro

Emole, Josephine; Lawal, Odunayo; Lupak, Oleksandra; Rangarajan, Hemalatha; Udo, Itoro.

Afiliación

Emole J; Stem Cell Transplantation and Cellular Therapy, Henry Ford Hospital, Detroit, MI, United States.
Lawal O; Clinical and Translational Science Program, University of Arizona, Tucson, AZ, United States.
Lupak O; Hematology/Oncology, Medical University of South Carolina, Charleston, SC, United States.
Rangarajan H; Hematology, Oncology & Blood and Marrow Transplant, Nationwide Children's Hospital, Columbus, OH, United States.
Udo I; Department of Psychiatry, Western University, London, Ontario, Canada.

Leuk Res Rep ; 19: 100364, 2023.

Article en En | MEDLINE | ID: mdl-36873581

Palabras clave

ALL, acute lymphoblastic leukemia; CART, chimeric antigen receptor T-cell; CI, confidence interval; Cancer; Chimeric antigen receptor T cell therapy; DLBCL, diffuse large B-cell lymphoma; FDA, Food and Drug Administration; HMO, Health Maintenance Organization; ICD-10, International Classification of Disease Tenth Revision; IQR, interquartile range; NIS, National Inpatient Sample; NPD, neuropsychiatric disorders; Neuropsychiatric disorders; Neurotoxicity; OR, odds ratio; Oncology; PMBCL, primary mediastinal large B-cell lymphoma; PTSD, post-traumatic stress disorder; SE, standard error; US, United States

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Leuk Res Rep Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Leuk Res Rep Año: 2023 Tipo del documento: Article